Treatment of Imminent Haematological Relapse in Patients With AML and MDS Following Allogeneic Stem Cell Transplantation With 5-azacitidine (Vidaza®)
Clinical trial NCT00422890 · COMPLETED
Trial details
- NCT number
- NCT00422890
- Sponsor
- Technische Universität Dresden
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-01
- Primary completion
- 2009-12-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.